Dell'Osso Bernardo, Shah Saloni, Do Dennis, Yuen Laura D, Hooshmand Farnaz, Wang Po W, Miller Shefali, Ketter Terence A
Department of Psychiatry, University of Milan, Fondazione IRCCS Ca'Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Int J Bipolar Disord. 2017 Dec;5(1):2. doi: 10.1186/s40345-017-0072-x. Epub 2017 Jan 25.
Bipolar disorder (BD) is a chronic, frequently comorbid condition characterized by high rates of mood episode recurrence and suicidality. Little is known about prospective longitudinal characterization of BD type II (BD II) versus type I (BD I) in relation to time to depressive recurrence and recovery from major depressive episode. We therefore assessed times to depressive recurrence/recovery in tertiary clinic-referred BD II versus I patients.
Outpatients referred to Stanford BD Clinic during 2000-2011 were assessed with Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and with Clinical Monitoring Form during up to 2 years of naturalistic treatment. Prevalence and clinical correlates of bipolar subtype in recovered (euthymic ≥8 weeks) and depressed patients were assessed. Kaplan-Meier analyses assessed the relationships between bipolar subtype and longitudinal depressive severity, and Cox proportional hazard analyses assessed the potential mediators.
BD II versus BD I was less common among 105 recovered (39.0 vs. 61.0%, p = 0.03) and more common among 153 depressed (61.4 vs. 38.6%, p = 0.006) patients. Among recovered patients, BD II was associated with 6/25 (24.0%) baseline unfavorable illness characteristics/mood symptoms/psychotropics and hastened depressive recurrence (p = 0.015). Among depressed patients, BD II was associated with 8/25 (33.0%) baseline unfavorable illness characteristics/mood symptoms/psychotropics, but only non-significantly associated with delayed depressive recovery.
BD II versus BD I was significantly associated with current depression and hastened depressive recurrence, but only non-significantly associated with delayed depressive recovery. Research on bipolar subtype relationships with depressive recurrence/recovery is warranted to enhance clinical management of BD patients.
双相情感障碍(BD)是一种慢性疾病,常伴有其他疾病,其特征为情绪发作复发率高和自杀倾向。关于II型双相情感障碍(BD II)与I型双相情感障碍(BD I)在抑郁复发时间和从重度抑郁发作中恢复方面的前瞻性纵向特征,我们所知甚少。因此,我们评估了三级临床转诊的BD II型与BD I型患者的抑郁复发/恢复时间。
2000年至2011年期间转诊至斯坦福双相情感障碍诊所的门诊患者,在长达2年的自然治疗期间,采用双相情感障碍系统治疗强化项目(STEP - BD)情感障碍评估和临床监测表进行评估。评估了康复(心境正常≥8周)和抑郁患者中双相亚型的患病率及其临床相关因素。Kaplan - Meier分析评估了双相亚型与纵向抑郁严重程度之间的关系,Cox比例风险分析评估了潜在的中介因素。
在105例康复患者中,BD II型比BD I型少见(39.0%对61.0%,p = 0.03);在153例抑郁患者中,BD II型比BD I型更常见(61.4%对38.6%,p = 0.006)。在康复患者中,BD II型与25例中的6例(24.0%)基线不良疾病特征/情绪症状/精神药物有关,且抑郁复发更快(p = 0.015)。在抑郁患者中,BD II型与25例中的8例(33.0%)基线不良疾病特征/情绪症状/精神药物有关,但与抑郁恢复延迟仅存在非显著相关性。
BD II型与BD I型与当前抑郁及抑郁复发加快显著相关,但与抑郁恢复延迟仅存在非显著相关性。有必要对双相亚型与抑郁复发/恢复之间的关系进行研究,以加强双相情感障碍患者的临床管理。